$CELC 0.23 Weak

Notable posts

• @ripster47 bullish 36 eng

  🚨 Our Biotech Porfolio hitting new highs today as Rotation into Biotechs $XBI $CELC $MEDP big winners for us Thanks to @Pharmdca $MEDP also big conviction by @PharmDabbler All ideas shared here before move Also Live Portfolio adds for https://t.co/3jEjW3yS30 members https://t.co/N1wMpudzfS

  view on X →
• @ripster47 bullish 39 eng

  $CELC 💡 Home Run Gap Fill setup Gave this setup in 83/85 Now 114 See before/after Follow @TenetCharts for more such setup Big winner for us in https://t.co/3jEjW3yS30 https://t.co/AyNfGbeWnG

  view on X →
• @ripster47 bullish 25 eng

  $XBI $IBB Biotech rotation today $LLY going bonkers $CELC Solid move $ABVX $RVMD

  view on X →
• @ripster47 bullish 16 eng

  $CELC Spike 🤔🚀 While huge winner already but some insane volume Scale out before binary Scale out before binary already and big part of our biotech portfolio ,small risk into PDUFA now 👇👇 https://t.co/foRHrky1RO

  view on X →
• @ripster47 bullish 16 eng

  $CELC going for Targets🚨 Ripping our portfolios higher Market red swing accounts new highs https://t.co/3jEjW3yS30 Gave the setup many times See before/after https://t.co/GrH1yMyU1U

  view on X →
• @ripster47 bullish 16 eng

  $CELC 💡🕯️ Buyout of $NUVL by $GSK at 10Billion is big Tailwind for $CELC https://t.co/JGDhtKCXMU

  view on X →
• @ripster47 bullish 13 eng

  $MEDP 🚨 Hit 671 from 386 Idea long that I gave on X tweets and in our portfolios at https://t.co/3jEjW3yS30 After $CELC another Big winner for X followers and Tenet Group members! https://t.co/eaN8v5Z5nk

  view on X →
• @TenetCharts bullish 35 eng

  $CELC 🚨 Best R/R setup in biotech From 151 back to 80s Consolidating for over 2 Weeks PDUFA in 1 Month Runup to start soon Void under key support levels HR+/HER2- breast cancer is one of the largest solid tumor markets globally, and resistance to CDK4/6 plus endocrine therapy is a growing clinical problem, so even a modestly differentiated PAM-pathway inhibitor can support blockbuster-level peak sales if it establishes a foothold in later lines and then moves earlier @Pharmdca

  view on X →